Namibia Registers Twice-a-Year HIV Prevention Drug

The Ministry of Health and Social Services has registered lenacapavir, a long-acting HIV prevention medication administered twice a year, as part of efforts to strengthen the country’s HIV prevention response.

This was announced in a statement by the ministry on Thursday afternoon.

The ministry says the registration was fast-tracked, placing Namibia among the first African countries to approve the next-generation pre-exposure prophylaxis (PrEP) option. South Africa and Zambia have already…